We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+4.78%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.1B
AUM Growth
+$1.27B
(+12%)
Cap. Flow
+$1.03B
Cap. Flow
% of AUM
8.56%
Top 10 Holdings %
Top 10 Hldgs %
10.66%
Holding
624
New
180
Increased
169
Reduced
84
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$135M |
| 2 |
NXP Semiconductors
NXPI
|
+$129M |
| 3 |
Diamondback Energy
FANG
|
+$103M |
| 4 |
Texas Instruments
TXN
|
+$98.4M |
| 5 |
Salesforce
CRM
|
+$96.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$217M |
| 2 |
Palo Alto Networks
PANW
|
+$120M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$120M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$110M |
| 5 |
Merck
MRK
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.27% |
| 2 | Industrials | 13.28% |
| 3 | Healthcare | 12.87% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Consumer Staples | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
351
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.67M | 0.03% |
356,215
+25,378
| +8% | +$232K |
|
352
TriplePoint Venture Growth BDC
TPVG
$211M
| $3.62M | 0.03% |
307,289
+2,449
| +0.8% | +$28.6K |
|
|
MR
353
DELISTED
Montage Resources Corporation Common Stock
MR
| $3.6M | 0.03% |
90,000
-136,667
| -60% | -$6.09M |
|
354
Manchester United
MANU
$3.73B
| $3.54M | 0.03% |
+248,548
| New | +$3.79M |
|
355
Theriva Biologics
TOVX
$10.1M
| $3.5M | 0.03% |
+524
| New | +$5.38M |
|
356
Equity Residential
EQR
$25.1B
| $3.4M | 0.03% |
52,810
-36,340
| -41% | -$2.23M |
|
357
Keurig Dr Pepper
KDP
$40.8B
| $3.36M | 0.03% |
+37,020
| New | +$3.25M |
|
|
OCLR
358
DELISTED
Oclaro Inc.
OCLR
| $3.35M | 0.03% |
374,658
-2,844,622
| -88% | -$24.6M |
|
359
Elevance Health
ELV
$85.5B
| $3.27M | 0.03% |
+22,766
| New | +$3.05M |
|
|
MYCC
360
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $3.25M | 0.03% |
+226,114
| New | +$3.01M |
|
|
CSLT
361
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $3.22M | 0.03% |
650,000
-45,064
| -6% | -$204K |
|
362
Covenant Logistics
CVLG
$872M
| $3.05M | 0.03% |
315,226
-36,518
| -10% | -$342K |
|
|
SQNS
363
Sequans Communications SA
SQNS
$41.3M
| $2.99M | 0.02% |
16,002
+6,002
| +60% | +$1.11M |
|
364
East-West Bancorp
EWBC
$18B
| $2.98M | 0.02% |
58,700
+4,994
| +9% | +$222K |
|
365
Zevra Therapeutics
ZVRA
$686M
| $2.95M | 0.02% |
62,421
+1,963
| +3% | +$121K |
|
366
Alexandria Real Estate Equities
ARE
$8.56B
| $2.93M | 0.02% |
+26,403
| New | +$2.83M |
|
|
QTNT
367
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $2.92M | 0.02% |
15,061
-939
| -6% | -$203K |
|
|
QTS
368
DELISTED
QTS REALTY TRUST, INC.
QTS
| $2.92M | 0.02% |
+58,727
| New | +$2.84M |
|
369
Extra Space Storage
EXR
$31.6B
| $2.89M | 0.02% |
+37,435
| New | +$2.76M |
|
|
BPMC
370
DELISTED
Blueprint Medicines
BPMC
| $2.81M | 0.02% |
+100,000
| New | +$3.01M |
|
|
AMTD
371
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.77M | 0.02% |
+63,413
| New | +$2.46M |
|
372
TechnipFMC
FTI
$27.3B
| $2.72M | 0.02% |
102,867
-2,320,899
| -96% | -$58.1M |
|
373
Vince Holding Corp
VNCE
$86.8M
| $2.71M | 0.02% |
66,855
+7,357
| +12% | +$351K |
|
374
Aclaris Therapeutics
ACRS
$869M
| $2.66M | 0.02% |
+97,854
| New | +$2.5M |
|
375
CNO Financial Group
CNO
$5.1B
| $2.64M | 0.02% |
+137,993
| New | +$2.37M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q4 2016 Portfolio in Review
As of Q4 2016, Alyeska Investment Group held 624 positions worth $12.1B, up 12% from $10.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Alyeska Investment Group deployed $1.03B of net new capital in Q4 2016, opening 180 new positions and adding to 169 existing holdings. Its largest new stake was Texas Instruments: 1,378,860 shares worth $101M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Palo Alto Networks, an estimated $120M trimmed.
- Alyeska Investment Group's largest Q4 2016 buy was Texas Instruments: 1,378,860 shares worth $101M.
- Alyeska Investment Group added most to Alphabet (Google) Class A in Q4 2016, an estimated $135M increase.
- Alyeska Investment Group's biggest Q4 2016 reduction was Palo Alto Networks, cutting an estimated $120M.
- Alyeska Investment Group fully exited Apple in Q4 2016, selling an estimated $217M.
- Alyeska Investment Group's ten largest holdings make up 11% of its $12.1B portfolio in Q4 2016.
- Alyeska Investment Group opened 180 new positions and closed 163 in Q4 2016.
- Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $12.1B.
Based on Alyeska Investment Group's 13F filing for Q4 2016, filed 14 Feb 2017.